Current Report Filing (8-k)
February 24 2017 - 05:03PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event
reported): February 17, 2017
NEUROTROPE, INC.
(Exact name of registrant as specified
in its charter)
Nevada
|
000-55275
|
46-3522381
|
(State or other jurisdiction
of incorporation)
|
(Commission File Number)
|
(IRS Employer
Identification No.)
|
205
East 42
nd
Street, 16
th
Floor
New York, New York 10017
(Address of principal executive offices and zip code)
Registrant’s telephone number,
including area code: (973) 242-0005
_____________________________________________________________________________________
(Former Name or Former Address, if Changed
Since Last Report)
Check the appropriate box below if the Form 8-K filing is
intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (
see
General
Instruction A.2. below):
|
¨
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
¨
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
¨
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
¨
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
|
Item 5.03
|
Amendments to Articles of Incorporation or Bylaws;
Change in Fiscal Year
|
On February 17, 2017, at a special meeting
of stockholders (the “
Special Meeting
”) of Neurotrope, Inc. (the “
Company
”), the stockholders
of the Company approved an amendment to the Company’s Articles of Incorporation (the “
Charter
”), to be
effective immediately, to increase the number of authorized shares of our common stock to 150,000,000 shares. The amendment was filed with the Secretary of State of the State of Nevada on February 24, 2017.
The amendment to the Charter is filed as
Exhibit 3.1 to this report and is incorporated by reference herein. The foregoing summary of the amendment is qualified in its
entirety by reference to the full text of the Charter, as amended.
|
Item 5.07.
|
Submission of Matters to a Vote of Security Holders.
|
(a) On February 17,
2017, the Company held the Special Meeting. As of January 13, 2017, the record date for the Special Meeting, there were 6,781,357
shares of our common stock outstanding and entitled to vote. At the Special Meeting, the holders of 4,467,178 shares were present
in person or represented by proxy, which represented 65.874% of the total shares entitled to vote at the Special Meeting.
(b) The following actions
were taken at the Special Meeting:
|
(1)
|
The amendment to the Company’s Charter to increase the number of authorized shares of our common stock to 150,000,000
shares, was approved, based on the following votes:
|
Votes For
|
Votes Against
|
Votes Abstain
|
Broker Non-Vote
|
3,934,287
|
427,485
|
51,934
|
53,472
|
|
(2)
|
The adjournment of the Special Meeting, if necessary, to solicit additional proxies if there are not sufficient votes in favor
of Proposal No. 1 was approved, based on the following votes:
|
Votes For
|
Votes Against
|
Votes Abstain
|
Broker Non-Vote
|
3,940,257
|
462,720
|
64,200
|
1
|
|
Item 9.01.
|
Financial Statements and Exhibits.
|
(d) Exhibits.
Exhibit
|
|
|
Number
|
|
Description
|
|
|
|
3.1
|
|
Neurotrope, Inc. Certificate of Amendment to Articles of Incorporation.
|
SIGNATURE
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
NEUROTROPE, INC.
|
|
|
|
Date: February 24, 2017
|
By: /s/ Robert Weinstein
|
|
Name:
|
Robert Weinstein
|
|
Title:
|
Chief Financial Officer, Executive Vice President, Secretary and Treasurer
|
NextTrip (NASDAQ:NTRP)
Historical Stock Chart
From Feb 2024 to Mar 2024
NextTrip (NASDAQ:NTRP)
Historical Stock Chart
From Mar 2023 to Mar 2024